Altria (MO) earnings call transcripts
Earnings call transcripts for Altria, with a summary, the guidance given, and what analysts pressed on.
- Q4 2025 earnings call
Management framed 2025 as strategic progress amid illicit-market pressure, with core tobacco funding measured smoke-free investment and shareholder returns.
Jan 29, 2026Mildly positive0.35 - Q3 2025 earnings call
Management framed the quarter around resilient core tobacco profits, smoke-free product development and regulatory progress, while emphasizing that consumer demand and competition remain dynamic.
Oct 30, 2025Positive0.55 - Q2 2025 earnings call
Management framed the quarter around resilient core cash generation, ON’s contribution, and regulatory enforcement as prerequisites for smoke-free growth.
Jul 30, 2025Mildly positive0.35 - Q1 2025 earnings call
Management framed the quarter around resilient core tobacco profitability and ON momentum, while stressing that illicit vapes and consumer pressure complicate the smoke-free transition.
Apr 29, 2025Mildly positive0.25 - Q3 2023 earnings call
Management framed the quarter around resilient legacy cash generation funding a smoke-free transition, while stressing illicit vaping’s growing disruption and enforcement gaps.
Oct 26, 2023Mildly positive0.25 - Q1 2023 earnings call
Management framed the quarter as on-plan despite consumer strain, emphasizing targeted brand support, smoke-free growth and regulatory enforcement over broad strategic change.
Apr 27, 2023Mildly positive0.24 - Q4 2022 earnings call
Management framed 2023 around balancing shareholder returns with smoke-free investment, while stressing that macroeconomic uncertainty—not a strategic shift—tempered its outlook.
Feb 01, 2023Mildly positive0.35